Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky bought 12,500 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were purchased at an average cost of $20.00 per share, with a total value of $250,000.00. Following the completion of the transaction, the director owned 12,500 shares in the company, valued at $250,000. This represents a ? increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Parabilis Medicines Stock Down 8.3%
NASDAQ PBLS traded down $2.25 on Monday, reaching $25.01. 1,280,260 shares of the stock traded hands, compared to its average volume of 1,305,491. Parabilis Medicines, Inc. has a 12 month low of $24.51 and a 12 month high of $34.47.
Read More
- Five stocks we like better than Parabilis Medicines
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
